Gene Delivery Using Physical Methods - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 113

[42] McMahon JM, Wells DJ. Electroporation for gene transfer to skeletal muscles: current
status. BioDrugs 2004;18:155-65.
[43] Bloquel C, Fabre E, Bureau MF, Scherman D. Plasmid DNA electrotransfer for intracel-
lular and secreted proteins expression: new methodological developments and applica-
tions. J Gene Med 2004;6:S11-23.
[44] �i S, Benninger M. Applications of muscle electroporation gene therapy. Curr Gene Ther
2002;2:101-5.
[45] Schertzer JD, �ynch GS. Plasmid-based gene transfer in mouse skeletal muscle by elec-
troporation. Methods Mol Biol 2008;433:115-25.
[46] Pang WK, Zhao Y, Peng J, Peng B, Xu Y. Therapeutic protein production in vivo after
electroporation-assisted intramuscular gene delivery. Engineering in Medicine and
Biology Society, Conference proceedings: Annual International Conference of the IEEE
Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and
Biology Society. Abstract Book; 2005, 6. p. 6229-32.
[47] Baowei P, Yonggang Z, Huili �, Wengka P, Yuhong Xu. In vivo plasmid DNA electropor-
ation resulted in transfection of satellite cells and lasting transgene expression in regener-
ated muscle fibers. Biochem Biophys Res Commun 2005;338:1490-8.
[48] Hyung SJ, Hyun JK, Jeong MK, Young S�, Koung �K, Jeong AK, et al. A novel ex vivo
angiogenesis assay based on electroporation-mediated delivery of naked plasmid DNA
to skeletal muscle. Poster Abstr/Cardiovasc Path 2004;13:S17-79.
[49] Chiarella P, Massi ED, Robertis M, Sibilio A, Parrella P, Fazio VM, et al. Electroporation
of skeletal muscle induces danger signal release and antigen-presenting cell recruitment
independently of DNA Vaccine administration. Expert Opin Biol Ther 2008;8:1645-57.
[50] Scheerlinck PY, Karlis J, Tjelle TE, Presidente PJA, Mathiesen I, Newton SE. In vivo
electroporation improves immune responses to DNA vaccination in sheep. Vaccine
2004;22:1820-5.
[51] Shawn B, Maria E, Baca E, Marianna F, Michael S, Deitmar R, et al. Electroporation
improves the efficacy of DNA Vaccine s in large animals. Vaccine 2002;20:3399-408.
[52] �i S, Xia X, Zhang X, Suen J. Regression of tumors by IFN-alpha electroporation gene
therapy and analysis of the responsible genes by cDNA array. Gene Ther 2002;9:390-7.
[53] �i S, Zhang X, Xia X, Zhou �, Breau R, Suen J, et al. Intramuscular electroporation
delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant
site. Gene Ther 2001;8:400-7.
[54] Yo-ichi Y, Mitsuo S, Hirofumi H, Ryosuke M, Tatsuya R, Takayuki H, et al.
Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the
mice model. Cancer Res 2001;61:1005-12.
[55] Yo-ichi Y, Mitsuo S, Ryosuke M, Eiji T, Norifumi H, Shinji T, et al. Muscle-targeted
interleukin-12 gene therapy of orthotopic hepatocellular carcinoma in mice using in vivo
electrosonoporation. Mol Cancer Ther 2004;3:1177.
[56] Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial
of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin
Oncol 2008;26:5896-903.
[57] Heller R, Jaroszeski M, Atkin A, Moradpour D, Gilbert R, Wands J, et al. In vivo gene
electroinjection and expression in rat liver. FEBS �ett 1996;389:225-8.
[58] Takeshi S, Shin BS, Keiko F, Toshiyuki M, Kuniaki T. Direct gene transfer into rat liver
cells by in vivo electroporation. FEBS �ett 1998;425:436-40.
[59] Matsuno Y, Iwata H, Umeda Y, Takagi H, Mori Y, Kosugi A, et al. Hepatocyte growth
factor gene transfer into the liver via the portal vein using electroporation attenuates rat
liver cirrhosis. Gene Ther 2003;10:1559-66.